HIGHLIGHTS
- who: TYPE et al. from the University of California, Davis, United States have published the article: Editorial: Advances in wild type and mutant p53 research in cancer, in the Journal: (JOURNAL) of 08/Oct/2022
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
SUMMARY
P53, gain of function (GOF), cancer, ferroptosis, zinc ionophores, p53 reactivation therapy, Drimia calcarata Editorial on the Research Topic Advances in wild_type and mutant p53 research in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.